SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
15668286
Source:
http://linkedlifedata.com/resource/pubmed/id/15668286
Search
Subject
(
61
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0017185
,
umls-concept:C0030705
,
umls-concept:C0235974
,
umls-concept:C0282460
,
umls-concept:C0346647
,
umls-concept:C0877373
,
umls-concept:C0877874
pubmed:issue
2
pubmed:dateCreated
2005-1-25
pubmed:abstractText
Troxacitabine (Troxatyl) is a novel L-enantiomer nucleoside analog with activity in pancreatic cancer xenograft models.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/9007735
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Cytosine
,
http://linkedlifedata.com/resource/pubmed/chemical/Dioxolanes
,
http://linkedlifedata.com/resource/pubmed/chemical/troxacitabine
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0923-7534
pubmed:author
pubmed-author:BatistGG
,
pubmed-author:EatockMM
,
pubmed-author:HawkinsR ERE
,
pubmed-author:JolivetJJ
,
pubmed-author:LétourneauRR
,
pubmed-author:LapointeRR
,
pubmed-author:MooreMM
,
pubmed-author:StewartGG
,
pubmed-author:VincentMM
,
pubmed-author:WhittonSS
pubmed:issnType
Print
pubmed:volume
16
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
289-93
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:15668286-Adult
,
pubmed-meshheading:15668286-Aged
,
pubmed-meshheading:15668286-Antineoplastic Agents
,
pubmed-meshheading:15668286-Body Weight
,
pubmed-meshheading:15668286-Cytosine
,
pubmed-meshheading:15668286-Dioxolanes
,
pubmed-meshheading:15668286-Disease Progression
,
pubmed-meshheading:15668286-Female
,
pubmed-meshheading:15668286-Health Status
,
pubmed-meshheading:15668286-Humans
,
pubmed-meshheading:15668286-Infusions, Intravenous
,
pubmed-meshheading:15668286-Male
,
pubmed-meshheading:15668286-Middle Aged
,
pubmed-meshheading:15668286-Pain
,
pubmed-meshheading:15668286-Pancreatic Neoplasms
,
pubmed-meshheading:15668286-Survival Analysis
,
pubmed-meshheading:15668286-Treatment Outcome
pubmed:year
2005
pubmed:articleTitle
Phase II study of troxacitabine in chemotherapy-naive patients with advanced cancer of the pancreas: gastrointestinal tumors.
pubmed:affiliation
Centre Hospitalier de l'Université de Montréal, St-Luc Hospital, Montreal, Quebec, Canada.
pubmed:publicationType
Journal Article
,
Clinical Trial
,
Research Support, Non-U.S. Gov't
,
Clinical Trial, Phase II